{
  "id": 3250,
  "url": "https://nnemf.org/research/3250-peripheral-pulsed-electromagnetic-fields-may-reduce-the-placebo",
  "title": "Peripheral pulsed electromagnetic fields may reduce the placebo effect in migraine patients that do not respond to the sham intervention in a randomized, placebo-controlled, double-blind, cross-over clinical trial.",
  "authors": [
    "Daniel San-Juan",
    "Ana Aurora L Pon",
    "Fernando Z Pohls",
    "Juan de Dios Del Castillo-Calcáneo",
    "Iván Pérez-Neri",
    "Camilo Ríos"
  ],
  "journal": "Complementary therapies in medicine",
  "year": "2012",
  "doi": "10.1016/j.ctim.2011.09.006",
  "pmid": "22305246",
  "abstract": "OBJECTIVE: The purpose of the study was to evaluate the effect of the pulsed electromagnetic fields (PEMF) and its possible modulation of the placebo effect in migraine. DESIGN: Placebo-controlled, randomized, double-blind, cross-over clinical trial. SETTING: Government third level hospital. INTERVENTIONS: Patients with migraine were included. PEMF were applied to the wrist with a bracelet. MAIN OUTCOME MEASURES: Frequency and intensity of the migraine attacks at baseline and during treatment were recorded. Also, we valuated the possible influence of gender and the presence of aura in the PEMF and placebo responses. RESULTS: Eighteen patients (fifteen women, 30±2 years old) were included. Migraine frequency and intensity was reduced with both PEMF and placebo to a similar extent in the whole population. However, in responders to placebo, migraine intensity was reduced to a median of 100% with the placebo and to 60% with the PEMF, while in non-responders there was only a slight effect of both treatments. Our results do not suggest an influence of gender or presence of aura in the outcomes. CONCLUSIONS: Treatment with PEMF may not alter either migraine intensity or frequency compared to baseline, but may reduce the response to placebo in migraine patients.",
  "effect": "mixed",
  "evidence": "low",
  "extraction": {
    "studyType": "randomized_trial",
    "studyTypeLabel": "randomized trial",
    "effectDirection": "mixed",
    "evidenceLabel": "Low",
    "population": "Patients with migraine",
    "sampleSize": "18",
    "exposure": "peripheral pulsed electromagnetic fields (PEMF) applied to the wrist with a bracelet",
    "confidencePct": "74",
    "peerReviewed": "yes",
    "mainFindings": "In the whole population, migraine frequency and intensity were reduced with both PEMF and placebo to a similar extent. Among placebo responders, migraine intensity was reduced to a median of 100% with placebo and to 60% with PEMF; among placebo non-responders there was only a slight effect of both treatments. The results did not suggest an influence of gender or presence of aura on outcomes.",
    "outcomes": [
      "Migraine attack frequency",
      "Migraine attack intensity",
      "Placebo response/modulation",
      "Influence of gender on response",
      "Influence of aura on response"
    ],
    "limitations": [
      "Small sample size (n=18)",
      "Exposure parameters (e.g.",
      "frequency",
      "field strength",
      "duration) not reported in abstract"
    ],
    "keywords": [
      "pulsed electromagnetic fields",
      "PEMF",
      "migraine",
      "placebo effect",
      "randomized",
      "double-blind",
      "cross-over",
      "bracelet",
      "wrist"
    ],
    "hubs": [],
    "raw": "{\n  \"study_type\": \"randomized_trial\",\n  \"exposure\": {\n    \"band\": null,\n    \"source\": \"peripheral pulsed electromagnetic fields (PEMF) applied to the wrist with a bracelet\",\n    \"frequency_mhz\": null,\n    \"sar_wkg\": null,\n    \"duration\": null\n  },\n  \"population\": \"Patients with migraine\",\n  \"sample_size\": 18,\n  \"outcomes\": [\n    \"Migraine attack frequency\",\n    \"Migraine attack intensity\",\n    \"Placebo response/modulation\",\n    \"Influence of gender on response\",\n    \"Influence of aura on response\"\n  ],\n  \"main_findings\": \"In the whole population, migraine frequency and intensity were reduced with both PEMF and placebo to a similar extent. Among placebo responders, migraine intensity was reduced to a median of 100% with placebo and to 60% with PEMF; among placebo non-responders there was only a slight effect of both treatments. The results did not suggest an influence of gender or presence of aura on outcomes.\",\n  \"effect_direction\": \"mixed\",\n  \"limitations\": [\n    \"Small sample size (n=18)\",\n    \"Exposure parameters (e.g., frequency, field strength, duration) not reported in abstract\"\n  ],\n  \"evidence_strength\": \"low\",\n  \"confidence\": 0.74,\n  \"peer_reviewed_likely\": \"yes\",\n  \"keywords\": [\n    \"pulsed electromagnetic fields\",\n    \"PEMF\",\n    \"migraine\",\n    \"placebo effect\",\n    \"randomized\",\n    \"double-blind\",\n    \"cross-over\",\n    \"bracelet\",\n    \"wrist\"\n  ],\n  \"suggested_hubs\": []\n}"
  },
  "synthesis": null,
  "synthesisStatus": "pending",
  "originalHref": "https://pubmed.ncbi.nlm.nih.gov/22305246/",
  "sourceUrl": "https://rfsafe.org/mel/paper.php?id=3250",
  "updated": "2026-02-13 07:12:43"
}